LEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2013-06-14 for LEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION UNK manufactured by Pluromed Inc..

Event Text Entries

[18055733] Continued to block the vessel [vascular occlusion]. Legoo plug migrated down the vessel [product solubility abnormal]. Case description: spontaneous report was received on (b)(4) 2013 from a surgeon via a sales representative regarding a patient (demographics not provided), initials unknown. The patient's medical history was not provided. On (b)(6) 2013, legoo (endovascular occlusion gel) was injected (dosage regimen not provided) in an unspecified vessel during a peripheral vascular bypass surgery on leg, for vascular occlusion. The lot number for legoo was not provided. It was reported that "legoo plug migrated down the vessel" and "continued block the vessel" even after anastomosis was finished being reconnected. The blockage occurred on distal side of anastomosis. The surgeon did flush the vessel with saline after the bypass and confirmed the reconnection, although the ultrasound after tightening down the vessel showed something in the vessel. The surgeon did pulse probe on the vessel and did not get a pulse on 2 cm to 3 cm of the vessel. Further the x-ray was done which also confirmed that something was blocking the vessel. It was reported that the surgeon pulled out something which was blocking the vessel. According to sales representative, the surgeon pulled out legoo from the vessel. The ultrasound and angiogram was performed which confirmed that the vessel was completely open. The sales representative reported that the surgeon might have used the incorrect technique to dissolve the legoo plug. The surgeon pushed the legoo plug down the vessel and cold saline never got all the way through the legoo plug to dissolve it all. It was reported that trainer was also present during the surgery. On the same day, the patient recovered from the event of "continued to block the vessel". The outcome of the event of "legoo plug migrated down the vessel" was not provided. Concomitant medications were not provided. The intensity for both the events was not provided. The relationship between legoo and both the events was not provided by the reporting surgeon.
Patient Sequence No: 1, Text Type: D, B5


[18408514] Manufacturer's comment: the benefit-risk relationship of legoo is not affected by this report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3008867907-2013-00005
MDR Report Key3204219
Report Source05,07
Date Received2013-06-14
Date of Report2013-06-10
Date of Event2013-05-15
Date Mfgr Received2013-06-10
Date Added to Maude2013-07-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactBRUNO MENDEZ
Manufacturer Street675 WEST KENDALL STREET
Manufacturer CityCAMBRIDGE MD 02142
Manufacturer CountryUS
Manufacturer Postal02142
Manufacturer Phone6177686173
Manufacturer G1PLUROMED INC.
Manufacturer Street175 NEW BOSTON STREET
Manufacturer CityWOBURN MA 01801
Manufacturer CountryUS
Manufacturer Postal Code01801
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION
Generic NameENDOVASCULAR OCCLUSION GEL
Product CodeOBC
Date Received2013-06-14
Model NumberUNK
Catalog NumberUNK
Lot NumberUNKNOWN
ID NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerPLUROMED INC.
Manufacturer AddressWOBURN MA US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2013-06-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.